Antiphospholipid antibodies and heart failure with preserved ejection fraction. The multicenter athero-aps study
Background. The prevalence of heart failure with preserved ejection fraction (HFpEF) in patients with antiphospholipid syndrome (APS) is unknown. Methods. A prospective multicenter cohort study including 125 patients was conducted: 91 primary APS (PAPS), 18 APS-SLE, and 16 carriers. HFpEF was diagno...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2021
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10362/125611 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/125611 |